ClinOne closes $3M series A funding led by Boulder Ventures
A company providing a single platform to support clients’ clinical trial journeys has closed a $3 million Series A funding.
Source: outsourcing-pharma.com
Page 39 - Alpine Immune Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alpine Immune Sciences Today - Breaking & Trending Today
ClinOne Closes Series A Funding Round
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Alpine Immune Sciences (NASDAQ:ALPN) Stock Price Passes Above 200-Day Moving Average of $7.19
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.19 and traded as high as $8.10. Alpine Immune Sciences shares last traded at $8.09, with a volume of 62,603 shares traded. Analyst Upgrades and Downgrades […]
Source: modernreaders.com
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Forecasted to Post Q1 2024 Earnings of ($0.23) Per Share
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) – Equities research analysts at Wedbush issued their Q1 2024 EPS estimates for Alpine Immune Sciences in a research note issued to investors on Friday, March 24th. Wedbush analyst R. Driscoll anticipates that the biotechnology company will post earnings per share of ($0.23) for the quarter. Wedbush […]
Source: etfdailynews.com
Alpine Immune Sciences, Inc. to Post Q1 2024 Earnings of ($0.41) Per Share, Oppenheimer Forecasts (NASDAQ:ALPN)
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) – Oppenheimer issued their Q1 2024 earnings per share estimates for shares of Alpine Immune Sciences in a research note issued to investors on Friday, March 24th. Oppenheimer analyst M. Breidenbach expects that the biotechnology company will post earnings of ($0.41) per share for the quarter. The […]
Source: etfdailynews.com